These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21769466)

  • 1. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
    Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y
    Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
    Yasuda T; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Doki Y
    Ann Surg Oncol; 2015 Aug; 22(8):2599-607. PubMed ID: 25524011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of
    Hamai Y; Hihara J; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Aoki Y; Furukawa T; Okada M
    Ann Surg Oncol; 2019 Jun; 26(6):1869-1878. PubMed ID: 30675704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
    J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prognosis and lymph node status using
    Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
    World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.
    Dong X; Sun X; Zhao X; Zhu W; Sun L; Huang Y; Li W; Wan H; Xing L; Yu J
    Oncotarget; 2017 Feb; 8(9):14969-14977. PubMed ID: 28122340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal FDG-PET/CT uptake influences outcome and relapse location among esophageal cancer patients submitted to chemotherapy or radiochemotherapy.
    Jimenez-Jimenez E; Mateos P; Ortiz I; Aymar N; Roncero R; Gimenez M; Pardo J; Sabater S
    Clin Transl Oncol; 2019 Sep; 21(9):1159-1167. PubMed ID: 30661172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer.
    Miyata H; Yamasaki M; Takahashi T; Murakami K; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Br J Surg; 2013 Oct; 100(11):1490-7. PubMed ID: 24037571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.
    Yasuda T; Yano M; Miyata H; Yamasaki M; Higuchi I; Takiguchi S; Fujiwara Y; Doki Y
    Surg Today; 2015 Mar; 45(3):335-45. PubMed ID: 24969049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
    Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.
    Miyata H; Yamasaki M; Makino T; Tatsumi M; Miyazaki Y; Takahashi T; Kurokawa Y; Takiguchi S; Mori M; Doki Y
    Br J Surg; 2016 Jan; 103(1):97-104. PubMed ID: 26506079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of venous invasion and maximum standardized uptake value of
    Jeon JH; Lee JM; Moon DH; Yang HC; Kim MS; Lee GK; Zo JI
    Eur J Surg Oncol; 2017 Feb; 43(2):471-477. PubMed ID: 27912930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
    Park SY; Kim DJ; Jung HS; Yun MJ; Lee JW; Park CK
    World J Surg; 2015 Dec; 39(12):2948-54. PubMed ID: 26324159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.